Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practiceShinri Sato, Yoko Ozawa, Mamoru Kamoshita et al.|Medicine|2017Cited by 25
Distinct Responsiveness to Intravitreal Ranibizumab Therapy in Polypoidal Choroidal Vasculopathy With Single or Multiple PolypsMisa Suzuki, Yoko Ozawa, Norihiro Nagai et al.|American Journal of Ophthalmology|2016Cited by 21